Novo Resources Corp last week provided an update on its upcoming drilling program at the Balla Balla Gold Project in Western Australia, marking the start of a busy exploration period for the company.
Executive co-chair and acting CEO Mike Spreadborough said the drilling campaign is expected to begin in the coming weeks, pending weather conditions in the Pilbara. He noted that this is the first of several programs planned for the year, with additional drilling to follow in New South Wales. "You'll see four months of news flow as these drilling programs roll through," he said.
Falcon Gold Corp (TSX-V:FG, OTC:FGLDF) earlier this week provided an update on its Great Burnt project in Newfoundland, where the company is conducting a drill program in an emerging high-grade copper belt.
CEO Karim Rayani discussed the latest developments, including the release of high-resolution images of drill core samples.
Protalix Biotherapeutics Inc (NYSE-A:PLX) chairman Eliot Forster joined Proactive to discuss the company's unique approach to drug manufacturing using plant cells instead of mammalian cells.
He explained that this method enhances purity, sustainability, and reproducibility, setting Protalix apart in the biotech space.
Ceres Power Holdings PLC (LSE:CWR, OTC:CPWHF) shares fell 10% to 64.15p on Friday after its final results - a cue for Panmure Liberum to slash its price target from 700p to 150p.
Even so, the broker is sticking with its ‘buy’ rating, arguing that the sell-off—largely triggered by Bosch walking away from its partnership—is overdone.
Chariot Ltd (AIM:CHAR, OTC:OIGLF) earlier this week joined the Proactive studio to catch investors up with its significant and recently announced progress in its renewable energy business.
The firm secured $175 million in financing for Etana Energy, its electricity trading joint venture in South Africa. The financing, provided by Norfund, Standard Bank, BII, and GuarantCo, ensures that Etana is fully funded and financially stable.
Santacruz Silver Mining Ltd (TSX-V:SCZ, OTC:SZSMF)’s plan to accelerate its debt payments to Glencore will save $40 million and clean up its balance sheet, making the company more attractive to investors, according to analysts at Atrium Research.
On Thursday, Santacruz announced that it has structured and implemented a new plan to exercise its option to accelerate its payments to Glencore in consideration for its Bolivian mining assets.
Panmure Liberum has reiterated its ‘buy’ rating on Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF) and maintained its price target at 3.6p, following interim results that confirmed the company is edging closer to maiden production.
The helium explorer and developer posted a first-half loss of $1.9m - expected at this pre-revenue stage - with net cash of $10m after a recent fundraise.
North Bay Resources Inc. (OTC:NBRI) said it has shipped a second test batch of 240 pounds of gold concentrate from its Bishop Gold Mill, processed from 10 tons of ore.
The junior resource company is optimizing operations at the Bishop Gold Mill, which processes ore from the Fran Gold Project.
Excellon Resources Inc (TSX:EXN, OTCQB:EXNRF) announced that new assay results from the Tres Cerros gold-silver project in Peru have confirmed the presence of a high-grade sulfidation epithermal system.
Assays have confirmed gold values reaching 9.3 grams per ton (g/t) and silver grades exceeding 1,000 g/t.
Greatland Gold PLC (AIM:GGP, OTC:GRLGF) CEO Shaun Day talked with Proactive about the company’s latest mineral resource update and its upcoming dual listing on the ASX. The update confirms 10.2 million ounces of gold and 387,000 tonnes of copper, significantly expanding the company's resource base.
Day highlighted that more than 55% of these resources fall under the measured and indicated category, allowing for future conversion to reserves. The company has also added 3.2 million ounces of gold and 117,000 tonnes of copper at the Telfer mine, strengthening its position in the market. "The size of the prize here in terms of life extension is really significant," he stated.
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF) chair James Smith hailed “a very exciting and significant period for the company”, as the AIM-quoted firm reported interim results.
“We now have a portfolio containing two development opportunities in two jurisdictions which diversifies the risk profile of the company and provides us with the opportunity, in Colorado, to realise near-term revenue streams which will support our future investment requirements across the portfolio,” Smith said.
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) has completed two major projects for AstraZeneca PLC (LSE:AZN), expanding the use of its Parsortix liquid biopsy system to support clinical trials in prostate and multiple cancer types.
The system isolates cancer cells from a simple blood sample, providing a non-invasive way to monitor how a patient’s disease is responding to treatment. This contrasts with traditional tissue biopsies, which are invasive and not always feasible to repeat.
Prescient Therapeutics Ltd is set to present data from its Phase 1b study of PTX-100 in T-cell lymphomas (TCLs) at the 16th Annual T-Cell Lymphoma Forum in La Jolla, California, this weekend.
Prescient Therapeutics CEO James McDonnell said: “This is a very timely meeting as we move to initiate our phase 2a study of PTX-100 in patients with relapsed and refractory cutaneous T-cell lymphomas (CTCL) next month.
Novo Resources Corp general manager of exploration Kas De Luca and executive co-chair and acting CEO Mike Spreadborough discuss the company's upcoming drilling program at the Balla Balla Gold project in WA.
Proactive: Mike, Kas, welcome.
Structural heart company Anteris Technologies Global Corp has fielded positive one-year results for patients treated with its proprietary DurAVR® Transcatheter Heart Valve (THV) System.
The latest data demonstrates the valve’s durability, hemodynamic performance and safety and bolsters the company’s mission – to develop innovative solutions for patients with structural heart disease.